How we work

Our role is to create a pathway to accelerate breakthrough research in advanced therapies to commercialisation and scale.

Wherever you are on your advanced therapy medicinal product (ATMP) development journey, we can help progress your products to market ensuring patients benefit from their immense potential

Supporting the needs of the sector 

We support the advancement of the entire ATMP sector identifying its most critical drivers and aligning our activities to address these effectively. We are committed to delivering impact across four key areas: 

  • New therapeutics  

    Supporting the development of novel ATMPs which provide effective treatments for more patients across a growing range of conditions. 

  • Lower cost of goods

    Driving innovation in manufacturing technologies to dramatically reduce production costs. 

  • Manufactured at scale

    Establishing a robust and scalable manufacturing sector capable of meeting the demands of a rapidly growing industry and widespread ATMP adoption. 

  • High uptake by healthcare systems 

    Facilitating efficient adoption systems and aligning healthcare system reimbursement models with innovative therapies to ensure broader patient access on a global scale. 

Learn more in our brochure

Advancing the cell and gene therapy industry through powerful collaborations

Click to view the PDF document

Working on a cell or gene therapy innovation challenge?

Contact us today to find out how we can support you.